Patents by Inventor Jung-Hyeon CHOI

Jung-Hyeon CHOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210134892
    Abstract: A display panel may include a first OLED disposed in a first sub-pixel region and emitting light of a first color, a second OLED disposed in a second sub-pixel region and emitting light of a second color, a third OLED disposed in a third sub-pixel region and emitting light of a third color, a fourth OLED disposed in a fourth sub-pixel region and emitting light of the second color, a first sub-pixel circuit disposed in the first sub-pixel region and driving the third OLED in the third sub-pixel region, a second sub-pixel circuit disposed in the second sub-pixel region and driving the first OLED in the first sub-pixel region, a third sub-pixel circuit disposed in the third sub-pixel region and driving the fourth OLED in the fourth sub-pixel region, and a fourth sub-pixel circuit disposed in the fourth sub-pixel region and driving the second OLED in the second sub-pixel region.
    Type: Application
    Filed: July 2, 2020
    Publication date: May 6, 2021
    Inventors: Young-In HWANG, Eung Taek Kim, Yong Ho YANG, Seong Min WANG, Joo Hyeon JO, Jung-Mi CHOI, Seong Baik CHU
  • Patent number: 10988406
    Abstract: Disclosed is fluorophosphate glasses for an active device, the fluorophosphate glasses including: a metaphosphate composition including Mg(PO3)2 of about 20 mol % to about 60 mol %; a fluoride composition including BaF2 of about 20 mol % to about 60 mol % and CaF2 of about 0 mol % to about 40 mol %; and dopants including rare earth elements, in which there is an effect of increasing a carrier lifetime at a metastable state energy level that is stimulated-emitted due to an efficient energy transfer phenomenon by composition optimization of dopants (e.g. Er and Yb).
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: April 27, 2021
    Assignee: KOREA PHOTONICS TECHNOLOGY INSTITUTE
    Inventors: Ju Hyeon Choi, Jung Whan In, June Park, Eui Sam Lee
  • Publication number: 20210093678
    Abstract: The present invention relates to an Agathobaculum sp. strain having prophylactic or therapeutic effects on autism spectrum disorders, and use thereof. When the intestinal microorganism Agathobaculum sp. strain of the present invention was orally administered to valproic acid (VPA)-induced autism model mice and BTBR autism model mice, the effects of remarkably improving autism spectrum disorders including repetitive behaviors, hyperactivity, social deficiency and cognitive/memory dysfunction of the mice were observed, as compared with a non-treated control. Accordingly, it may be usefully applied to foods, drugs, or feeds for preventing or treating autism spectrum disorders, and thus is very useful in the relevant industries.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 1, 2021
    Inventors: Byoung Chan KIM, Kyoung Shim KIM, Chul Ho LEE, Dong Ho CHANG, Yong-Hoon KIM, Jung-Ran NOH, Dong Hui CHOI, Jung Hwan HWANG, Jun GO, Jaehun KIM, Hye-Yeon PARK, Yun-Jung SEO, Young-Kyoung RYU, In-Bok LEE, Young Keun CHOI, Jung-Hyeon CHOI
  • Patent number: 10695390
    Abstract: The present invention relates to: a composition comprising a Sicyos angulatus extract or a fraction thereof as an effective ingredient for preventing, alleviating, or treating liver diseases; and a method for preventing or treating liver diseases, comprising a step of administering the composition to a subject suspected of having a liver disease.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: June 30, 2020
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Chul Ho Lee, Yong-Hoon Kim, Jung Ran Noh, Dong Hui Choi, Jung Hwan Hwang, Kyoung Shim Kim, Yun-Jung Seo, In-Bok Lee, Jung-Hyeon Choi
  • Publication number: 20190314425
    Abstract: The present disclosure relates to an Akkermansia muciniphila strain having a prophylactic or therapeutic effect on a degenerative brain disease and uses thereof. Since the Akkermansia muciniphila strain, the intestinal microorganism of the present disclosure, shows an effect of improving movement control and cognitive abilities as well as memory in an animal model having a degenerative brain disease such as Parkinson's disease and Alzheimer's disease, it can be useful in the prevention or treatment of brain diseases including Alzheimer's disease, Parkinson's disease, mild cognitive impairment, etc. In addition, it was confirmed in the present disclosure that compared to the Akkermansia muciniphila strain cultured in a mucin-containing medium, that cultured in a mucin-free medium showed a remarkable effect of improving hyperlipidemia, fatty liver, obesity, and hyperglycemia induced in a mouse model by high-fat diet when administered orally (in vivo).
    Type: Application
    Filed: July 11, 2017
    Publication date: October 17, 2019
    Inventors: Byoung-Chan KIM, Chul-Ho LEE, Jung-Ran NOH, Kyoung-Shim KIM, Myung-Hee KIM, Yong-Hoon KIM, Sang Jun LEE, Dong-Ho CHANG, Dong-Hee CHOI, Jung Hwan HWANG, Yun-Jung SEO, In-Bok LEE, Young-Keun CHOI, Jung-Hyeon CHOI
  • Publication number: 20190300972
    Abstract: Provided are an Agathobaculum sp. strain having prophylactic or therapeutic effects on degenerative brain diseases, and use thereof. Since the intestinal microorganism Agathobaculum butyriciproducens SR79 strain of the present invention may have effects of inhibiting neuroinflammation and effects of improving movement regulation and cognitive and memory functions in animal models with degenerative brain diseases such as Parkinson's disease and Alzheimer's disease, the strain may be effectively used in foods, medicines, or feeds for preventing or treating brain diseases including Alzheimer's disease, Parkinson's disease, mild cognitive impairment, etc., and therefore, it is very useful in the relevant industries.
    Type: Application
    Filed: June 14, 2017
    Publication date: October 3, 2019
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH NOLOGY
    Inventors: Byoung-Chan KIM, Chul-Ho LEE, Kyoung-Shim KIM, Myung-Hee KIM, Sang Jun LEE, Dong-Ho CHANG, Doo-Sang PARK, Jung Hwan HWANG, Yong-Hoon KIM, Dong-Hee CHOI, Jung-Ran NOH, In-Bok LEE, Young-Keun CHOI, Yun-Jung SEO, Jung-Hyeon CHOI, Jun GO, Hye-Yeon PARK, Young-Kyoung RYU, Moon-Soo RHEE
  • Publication number: 20180360897
    Abstract: The present invention relates to: a composition comprising a Sicyos angulatus extract or a fraction thereof as an effective ingredient for preventing, alleviating, or treating liver diseases; and a method for preventing or treating liver diseases, comprising a step of administering the composition to a subject suspected of having a liver disease.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Chul Ho LEE, Yong-Hoon KIM, Jung Ran NOH, Dong Hui CHOI, Jung Hwan HWANG, Kyoung Shim KIM, Yun-Jung SEO, In-Bok LEE, Jung-Hyeon CHOI